Treatment of Vaginal Trichomoniasis in Patients Allergic to Metronidazole

Primary Management Options

The Centers for Disease Control and Prevention recommends metronidazole desensitization as the first-line approach for patients with documented allergy to metronidazole 3
Desensitization should be performed under medical supervision with appropriate monitoring for allergic reactions 1, 2

The Centers for Disease Control and Prevention does not recommend metronidazole gel for trichomoniasis treatment as it achieves cure rates of less than 50% compared to 90-95% with oral therapy 3, 4
Treatment of sexual partners is essential to prevent reinfection regardless of which treatment approach is used 1, 2, 3
Patients should avoid sexual activity until both they and their partner(s) have completed treatment and are asymptomatic 3
For patients with persistent infection despite treatment, consultation with specialists is recommended 3
Untreated trichomoniasis is associated with adverse outcomes including increased risk of HIV transmission and pregnancy complications, making effective treatment crucial despite the challenges of medication allergy 1, 2